Pharmaceutical Contract Packaging Market | USD 34.57 Billion by 2034
The pharmaceutical contract packaging market size was exhibited at USD 17.25 billion in 2024 and is projected to hit around USD 34.57 billion by 2034, growing at a CAGR of 7.2% during the forecast period 2024 to 2034.
| Report Coverage | Details |
| Market Size in 2025 | USD 1.86 Billion |
| Market Size by 2034 | USD 5.41 Billion |
| Growth Rate From 2024 to 2034 | CAGR of 12.6% |
| Base Year | 2024 |
| Forecast Period | 2024-2034 |
| Segments Covered | Component, Delivery Model, Function, End-use, Disorder |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional Covered | North America, Europe, Asia Pacific, Latin America, MEA |
| Key Companies Profiled | Oracle (Cerner Corporation); Core Solutions, Inc.; Epic Systems Corporation; Meditab; Holmusk; Netsmart Technologies, Inc.; Qualifacts; Welligent; SimplePractice, LLC; TherapyNotes, LLC.; TheraNest |
Driven by the increasing trend of outsourcing packaging operations to specialized contract packaging companies. Facing pressure to cut costs and increase operational efficiency, pharmaceutical companies find outsourcing an effective solution. By partnering with packaging suppliers, they can focus on their core activities, such as drug discovery and development, leaving behind complex packaging, including compliance with regulatory requirements and managing new packaging for outside experts.
Another key factor driving the market's growth is the demand for customized, complex packaging products such as biologics, biosimilars, and personalized medicines that require specialized packaging. For instance, biologics and injectables often require temperature-controlled, sterile, non-deformable packaging to ensure packaging stability and safety. Contract packaging suppliers have increasingly deployed the technical capabilities and resources to handle these complex packaging requirements, ensuring that pharmaceutical companies deliver quality to consumers while meeting stringent regulatory standards.
Moreover, pharmaceutical products are subject to safety regulations, such as serialization requirements for traceability and compliance with Good Manufacturing Practices (GMP), ensuring that packaging adheres to the specific guidelines of regulatory bodies such as the FDA, EMA, and other regional agencies. Since packaging is critical to drug safety and counterfeit assurance, pharmaceutical companies have increasingly relied on experienced contract packagers to meet these evolving regulatory requirements and drive overall market expansion.
Primary packaging led segment dominating the market with the largest revenue share of 76.6% in 2024 due to the essential role primary packaging plays in safeguarding the pharmaceutical product’s integrity, safety, and compliance. Primary packaging includes direct contact materials such as blister packs, bottles, vials, and ampoules. Furthermore, primary packaging is often the first point of interaction between the drug and the consumer, making its design and functionality crucial for patient safety and product performance, thus driving the significant demand for primary packaging services in the pharmaceutical industry.
The secondary packaging segment is expected to grow significantly over the forecast period, driven by the increasing need for enhanced branding, consumer safety, and regulatory compliance. Secondary packaging, including outer packaging such as cartons, boxes, labels, and instructions, is the first defense in protecting the product during transportation. Secondary packaging plays a crucial role in serialization and traceability requirements, which are increasingly mandatory in many countries to prevent counterfeiting and ensure compliance with safety standards, providing clear product information and enhancing patient safety is growing.
The plastics and polymers segment contributed the largest revenue share, 42.0%, by 2024, mainly due to their versatility, cost-effectiveness, durability, ease of manufacturing, and ability to be molded into various shapes and sizes. These materials are ideal for special packaging such as bottles, blister packs, vials, and ampoules, commonly used in the pharmaceutical industry. In addition, plastics and polymers can be easily tailored to specific regulatory requirements for sterility, tamper proof, and child resistance, making them popular materials for chemical packaging.
The paper & page segment is expected to grow at the highest CAGR of 7.65% during the forecast period, driven by increasing demand for sustainable, non-conductive packaging of the environment. With growing environmental concerns about plastic waste and sustainability, more and more companies are adopting biodegradable and recyclable materials that do not impact the environment. Paper and paper board are low-cost and versatile renewable resources, making them attractive alternatives to secondary materials.
North America's pharmaceutical contract packaging market has dominated the global market and accounted for the largest revenue share of 36.0% in 2024 due to the region’s highly established pharmaceutical industry, technological advancements, and regulations. This ensures that North America is equipped with the latest technologies to meet the complex needs of a wide range of pharmaceutical packaging, including biologics, vaccines, and advanced therapies. The ability of North American packaging providers to manage these complex needs, highly skilled workers, and advanced infrastructure continues to position them as the leading global player in the medicine contract packaging market.
U.S. Pharmaceutical Contract Packaging Market Trends
The U.S. pharmaceutical contract packaging market in North America dominated, with the largest revenue share in 2024. This is due to the country’s advanced pharmaceutical capacity and extensive and heavily regulated healthcare system. innovations in packaging. The market is also fueled by innovations in packaging technologies, such as non-tampering, child-resistant, and anti-counterfeiting, which are critical to maintaining chemical safety and regulatory compliance, driving the market Demand for packaging solutions
Asia Pacific Pharmaceutical Contract Packaging Market Trends
Asia Pacific pharmaceutical contract packaging market is expected to grow at a CAGR of 7.74% over the forecast period, driven by rapidly advanced technologies, growing healthcare demand, and increasing outsourcing of services in the Asian region. Asia Pacific contract packaging services offer competitive pricing, advanced technology and large-scale manufacturing capabilities, driving the industry’s market growth. For instance, India is a global leader in the generic pharmaceutical industry and relies heavily on contract packaging services to meet domestic and international needs.
Europe Pharmaceutical Contract Packaging Market Trends
The growth of Europe's pharmaceutical contract packaging market is driven by an increasing demand for high-quality packaging solutions, stringent regulations, and the growing prevalence of personalized medicines. Europe is one of the most well-regulated pharmaceutical markets, ensuring that packaging meets safety, security, and traceability standards.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the pharmaceutical contract packaging market
By Type
By Material
By Regional
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Pharmaceutical Contract Packaging Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Pharmaceutical Contract Packaging Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Pharmaceutical Contract Packaging Market: Type Estimates & Trend Analysis
4.1. Type Market Share, 2024 & 2034
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2021 to 2034 (USD Billion)
4.4. Primary Packaging
4.4.1. Primary Packaging Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Billion)
4.4.2. Bottles
4.4.2.1. Bottles Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Billion)
4.4.3. Vials
4.4.3.1. Vials Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Billion)
4.4.4. Ampoules
4.4.4.1. Ampoules Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Billion)
4.4.5. Blister Packs
4.4.5.1. Blister Packs Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Billion)
4.4.6. Others
4.4.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Billion)
4.5. Secondary Packaging
4.5.1. Secondary Packaging Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Billion)
4.6. Tertiary Packaging
4.6.1. Tertiary Packaging Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Billion)
Chapter 5. Pharmaceutical Contract Packaging Market: Material Estimates & Trend Analysis
5.1. Material Market Share, 2024 & 2034
5.2. Material Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Material, 2021 to 2034 (USD Billion)
5.4. Plastics & Polymers
5.4.1. Plastics & Polymers Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Billion)
5.5. Paper & Paperboard
5.5.1. Paper & Paperboard Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Billion)
5.6. Glass
5.6.1. Glass Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Billion)
5.7. Aluminum Foil
5.7.1. Aluminum Foil Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Billion)
5.8. Others
5.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Billion)
Chapter 6. Pharmaceutical Contract Packaging Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2034
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2021 to 2034:
6.4. North America
6.4.1. North America Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Framework
6.4.2.3. Competitive Insights
6.4.2.4. U.S. Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Framework
6.4.3.3. Competitive Insights
6.4.3.4. Canada Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Regulatory Framework
6.4.4.3. Competitive Insights
6.4.4.4. Mexico Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.5. Europe
6.5.1. Europe Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Framework
6.5.2.3. Competitive Insights
6.5.2.4. UK Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Framework
6.5.3.3. Competitive Insights
6.5.3.4. Germany Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Framework
6.5.4.3. Competitive Insights
6.5.4.4. France Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Regulatory Framework
6.5.5.3. Competitive Insights
6.5.5.4. Italy Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Regulatory Framework
6.5.6.3. Competitive Insights
6.5.6.4. Spain Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.5.7. Sweden
6.5.7.1. Key Country Dynamics
6.5.7.2. Regulatory Framework
6.5.7.3. Competitive Insights
6.5.7.4. Sweden Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.5.8. Denmark
6.5.8.1. Key Country Dynamics
6.5.8.2. Regulatory Framework
6.5.8.3. Competitive Insights
6.5.8.4. Denmark Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.5.9. Norway
6.5.9.1. Key Country Dynamics
6.5.9.2. Regulatory Framework
6.5.9.3. Competitive Insights
6.5.9.4. Norway Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.6. Asia Pacific
6.6.1. Asia Pacific Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Framework
6.6.2.3. Competitive Insights
6.6.2.4. Japan Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Framework
6.6.3.3. Competitive Insights
6.6.3.4. China Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Framework
6.6.4.3. Competitive Insights
6.6.4.4. India Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.6.5. Thailand
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Framework
6.6.5.3. Competitive Insights
6.6.5.4. Thailand Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.6.6. South Korea
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Framework
6.6.6.3. Competitive Insights
6.6.6.4. South Korea Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.6.7. Australia
6.6.7.1. Key Country Dynamics
6.6.7.2. Regulatory Framework
6.6.7.3. Competitive Insights
6.6.7.4. Australia Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.7. Latin America
6.7.1. Latin America Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Framework
6.7.2.3. Competitive Insights
6.7.2.4. Brazil Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Framework
6.7.3.3. Competitive Insights
6.7.3.4. Argentina Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.8. Middle East and Africa
6.8.1. Middle East and Africa Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Framework
6.8.2.3. Competitive Insights
6.8.2.4. South Africa Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Regulatory Framework
6.8.3.3. Competitive Insights
6.8.3.4. Saudi Arabia Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Regulatory Framework
6.8.4.3. Competitive Insights
6.8.4.4. UAE Pharmaceutical Contract Packaging Market Estimates and Forecasts, 2021 - 2034 (USD Billion)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Amcor plc
7.5.1.1. Participant’s Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Recent Developments/ Strategic Initiatives
7.5.2. BALL CORPORATION
7.5.2.1. Participant’s Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Recent Developments/ Strategic Initiatives
7.5.3. Nipro Corporation
7.5.3.1. Participant’s Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Recent Developments/ Strategic Initiatives
7.5.4. Daito Pharmaceutical Co. Ltd
7.5.4.1. Participant’s Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Recent Developments/ Strategic Initiatives
7.5.5. Pfizer CentreOne
7.5.5.1. Participant’s Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Recent Developments/ Strategic Initiatives
7.5.6. CELESTICA INC.
7.5.6.1. Participant’s Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Recent Developments/ Strategic Initiatives
7.5.7. West Pharmaceutical Services, Inc.
7.5.7.1. Participant’s Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Recent Developments/ Strategic Initiatives
7.5.8. WestRock Company
7.5.8.1. Participant’s Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Recent Developments/ Strategic Initiatives
7.5.9. Patheon
7.5.9.1. Participant’s Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Recent Developments/ Strategic Initiatives
7.5.10. Baxter BioPharma Solutions
7.5.10.1. Participant’s Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Recent Developments/ Strategic Initiatives
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers